Galen Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Galen Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013993
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Galen Ltd (Galen), a subsidiary of Almac Group Ltd is a marketer of pharmaceutical products. The company’s products include trustsaver, calceos, salivix, daunoxome, flotros, histofreezer, laxido, and saline steripoules, among others. It offers products in various therapy areas including angina, constipation, HIV-related Kaposi’s sarcoma (KS), osteoporosis, overactive bladder, painful bladder syndrome and interstitial cystitis, and skin lesions and warts. Galen partners with international pharmaceutical and biotech companies to commercialize and expand its products. The company markets its products across the UK, Ireland, Europe and the US. It operates in the UK and the US. Galen is headquartered in Craigavon, the UK.

Galen Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Galen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Galen Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Galen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Galen Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Galen Acquires US Rights to ADASUVE from Alexza Pharma 11
Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 12
Galen Acquires DaunoXome, Chemotherapy Agent, From Gilead Sciences 13
Licensing Agreements 14
Galen Enters into Licensing Agreement with Medical Developments International for Penthrox 14
Galen Ltd – Key Competitors 15
Galen Ltd – Key Employees 16
Galen Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Galen Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Galen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Galen Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Galen Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Galen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Galen Acquires US Rights to ADASUVE from Alexza Pharma 11
Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 12
Galen Acquires DaunoXome, Chemotherapy Agent, From Gilead Sciences 13
Galen Enters into Licensing Agreement with Medical Developments International for Penthrox 14
Galen Ltd, Key Competitors 15
Galen Ltd, Key Employees 16
Galen Ltd, Subsidiaries 17

★海外企業調査レポート[Galen Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anteo Diagnostics Ltd (ADO):企業の製品パイプライン分析2018
    Summary Anteo Diagnostics Ltd (Anteo Diagnostics) is a leading medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries provides immunoassays, in-vitro diagnostics, and point of care (PoC) tests to life sciences, bio-separation, clinica …
  • Inframark LLC:企業の戦略的SWOT分析
    Inframark LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Medical College of Wisconsin-医療機器分野:企業M&A・提携分析
    Summary Medical College of Wisconsin (MCW) is a medical educational institution that offers biomedical education, patient care and research services. The college provides medical courses in the fields of biomedical sciences, post-doctoral education, patient and public health. It offers these courses …
  • Ethicon US LLC:製品パイプライン分析
    Summary Ethicon US LLC (Ethicon), a subsidiary of Johnson and Johnson, is a medical equipment company which operates through Ethicon Inc, and Ethicon Endo-Surgery Inc. It develops and markets surgical instruments and devices. Its major products include staplers, energy devices, clip appliers, trocar …
  • AVEO Pharmaceuticals Inc (AVEO):製薬・医療:M&Aディール及び事業提携情報
    Summary AVEO Pharmaceuticals Inc (AVEO) is a biopharmaceutical company which focuses on the discovery, development and commercialization of drugs for the treatment of various types of cancers. Its proprietary platform delivers insights into cancer and related diseases. AVEO develops its lead candida …
  • Zirax Ltd:企業の戦略的SWOT分析
    Zirax Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Arbutus Biopharma Corp (ABUS):企業の財務・戦略的SWOT分析
    Arbutus Biopharma Corp (ABUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • University of Pittsburgh:企業のM&A・事業提携・投資動向
    University of Pittsburgh - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Pittsburgh Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Total SA (FP):企業の財務・戦略的SWOT分析
    Total SA (FP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Centrais Eletricas Brasileiras S.A.:企業の戦略・SWOT・財務情報
    Centrais Eletricas Brasileiras S.A. - Strategy, SWOT and Corporate Finance Report Summary Centrais Eletricas Brasileiras S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Color Genomics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Color Genomics, Inc. (Color) provides physician ordered genetic testing service that helps to identify hereditary cancer risk. The company’s clinical grade test provides actionable results that enable consumers and their doctors to create personalized screening and healthcare plan. Color ana …
  • GP Pharm SA:製薬・医療:M&Aディール及び事業提携情報
    Summary GP Pharm SA (GP Pharm) is a biopharmaceutical company that develops and markets injectables in the areas of oncology and urology. The company provides product portfolio such as injectable dosage forms for the treatment of advanced prostate cancer; nocturnal enuresis and central diabetes insi …
  • Oman Air (SAOC):企業の戦略・SWOT・財務情報
    Oman Air (SAOC) - Strategy, SWOT and Corporate Finance Report Summary Oman Air (SAOC) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • WellCare Health Plans, Inc.:企業の戦略・SWOT・財務情報
    WellCare Health Plans, Inc. - Strategy, SWOT and Corporate Finance Report Summary WellCare Health Plans, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Energy Fuels Inc (EFR):企業の財務・戦略的SWOT分析
    Energy Fuels Inc (EFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Radico Khaitan Ltd.:企業の戦略・SWOT・財務分析
    Radico Khaitan Ltd. - Strategy, SWOT and Corporate Finance Report Summary Radico Khaitan Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Proofpoint Inc (PFPT):企業の財務・戦略的SWOT分析
    Proofpoint Inc (PFPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Prosetta Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prosetta Biosciences Inc (Prosetta Biosciences), formerly Prosetta Antiviral Inc is a developer of novel small-molecule antiviral drugs based on research on the cell-free protein synthesizing systems. The company uses cell-free protein synthesizing systems to identify new protein-protein int …
  • Indianapolis Power & Light Co:企業の発電所・SWOT分析2018
    Indianapolis Power & Light Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • SYNNEX Corp (SNX):企業の財務・戦略的SWOT分析
    SYNNEX Corp (SNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆